Precision oncology adjusts cancer treatment to patients' distinctive requirements using genetic profiles and particular tumour characteristics. This method significantly boosts therapy results by enabling oncologists to pick a treatment that corresponds with genetic modifications seen in tumours. Considering its potential, there are still many obstacles to overcome, like the difficulty of incorporating data and the limited affordability of comprehensive genomic testing. Robust bioinformatics platforms that make it easier to analyse genomic data and extend testing availability are required to overcome these difficulties..